[1] 沈 丹,薛 婧,张 蕊,等.某三甲医院鲍曼不动杆菌耐药性分析 [J].武警医学.2013.24(10):869-871.
[2] Clinical, Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing[S]. Twenty-Fourth Informational Supplement, 2014, M100-S24.
[3] Rosenthal V D, lvarez-Moreno C, Villamil-Gómez W, et al. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings [J]. Am J Infect Control, 2012, 40(6): 497-501.
[4] 俞云松.多药耐药鲍曼不动杆菌21世纪革兰阴性菌的“MRSA”[J].中华临床感染病杂志,2009,2(2):65-68.
[5] 陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85.
[6] Rajamohan G, Srinivasan V B, Gebreyes W A. Molecular and functional characterization of a novel efflux pump, AmvA, mediating antimicrobial and disinfectant resistance in Acinetobacter baumannii [J]. J Antimicrob Chemother, 2010, 65(9): 1919-1925.
[7] 杜 鹃,谢 峻,郑颖城,等.《抗生素耐药:全球监测报告2014》解读与反思[J].华南国防医学杂志,2014,28(8):814-817.
[8] 张建明,金 跃,糜祖煌,等.耐药鲍曼不动杆菌β内酰胺酶ADC基因和膜孔蛋白carO基因新变异型[J].中华检验医学杂志,2013,36(3):255-257.